Clinical applications of fibroblast activation protein‐targeted theranostics in oncologic and nononcologic disease: Current status and future directions

Abstract Quinoline‐based fibroblast activation protein (FAP) inhibitor (FAPI)‐based positron emission tomography (PET) imaging and radioligand therapy (RLT) are being investigated for use in a wide variety of diseases, and recent results have been promising. This review summarizes the current status...

Full description

Bibliographic Details

Published in:	iRADIOLOGY
Main Authors:	Hao Fu, Wei Guo, Jingxiong Huang, Hua Wu, Haojun Chen
Format:	Article
Language:	English
Published:	Wiley 2023-12-01
Subjects:	FAPI‐PET FAP‐targeted radioligand therapy FAP‐targeted theranostics fibroblast activation protein radiopharmaceuticals
Online Access:	https://doi.org/10.1002/ird3.46